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Serial technetium-99m radionuclide ventriculograms, indium-Ill 
antimyosin antibody scans and tissue biodistribution studies were 
performed in C3H1He mice with experimentally induced viral 
encephalomyocarditis and the results were compared with patho-
logic assessments of myocardial necrosis. Postinfection ejection 
fraction decreased on days 10 (20.7 ± 5.5%, n = 6), 20 (18.6 ± 
15.2%, n = 5), 30 (18.5 ± 7.7%, n = 5) and 150 (30.0 ± 18.7, n 
= 6) (p < 0.001) in comparison with that in uninfected control 
mice (63.3 ± 3.1 %, n = 6). 
In the same group of animals, indium-Ill antimyosin anti-
body scans showed intense positive myocardial accumulation 
on day 10 (in six of six mice) and only slight accumulation 
on day 20 (in one of five mice). In the chronic stage, two of 
five mice on day 30 and two of six mice on day 150 
still showed positive uptake. The antimyosin scan myocardium 
to lung uptake ratio (expressed as mean count density [mean 
counts/pixel of the region] ratio) increased greatly on day 10 
With the increasing use of myocardial biopsy, myocarditis is 
becoming more widely diagnosed (1,2). Subacute and 
chronic forms of myocarditis have been recognized as im-
portant causes of morbidity and mortality, and myocarditis 
is now accepted as one of the important primary as well as 
contributory causes of chronic dilated cardiomyopathy (2-
4). In most cases, the diagnosis of myocarditis is based on 
clinical findings. However, a definitive diagnosis requires 
positive evidence of myocarditis by histologic examination. 
The sensitivity of right ventricular endomyocardial biopsy is 
not satisfactory; in view of the focal nature of myocarditis, 
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(p < 0.001 versus values in uninfected control mice) but not 
subsequently. 
Biodistribution studies of the indium-ll1 antimyosin antibody 
showed that the heart to blood count ratio was significantly higher 
on day 10 (p < 0.001 versus values in control mice) but not on days 
20, 30 and 150. Pathologic examination showed active and ongoing 
severe myocardial necrosis with dilated ventricles on day 10. On 
day 20, there was less active necrosis and healing had appeared to 
begin. On days 30 and 150, myocardial fibrosis increased. 
This study reveals a depression in cardiac function in the acute 
stage of myocarditis that correlates with severe myocardial necro-
sis and intense uptake of radiolabeled antimyosin. Severe left 
ventricular dysfunction appeared within 10 days of infection with 
the encephalomyocarditis virus and continued until day 30. After 
5 months, left ventricular function improved in mice that had 
survived. 
(J Am Coil CardioI1991;17:821-7) 
endomyocardial biopsy may lack sensitivity because it may 
fail to sample a sufficient number of myocardial sites (1). 
Recently, indium-Ill monoclonal anti myosin antibody im-
aging has been used to clinically diagnose myocarditis (5,6). 
Because of our interest in viruses as a cause of cardiomy-
opathy, we (7,8) previously studied cardiac lesions produced 
by the encephalomyocarditis virus in C3H1He mice. 
In the present study, we attempt to answer three questions: 
1) Does acute viral myocarditis cause a decrease in left ven-
tricular ejection fraction? If it does, what are the characteristics 
of the time course of this decrease? Do the animals deteriorate 
slowly or rapidly, or do they recover 5 months after the 
infection? 2) Does the time course of the effect of the disease on 
left ventricular ejection fraction correlate with pathologic char-
acteristics of myocarditis? 3) Can a noninvasive diagnosis of 
the presence of myocardial cell necrosis by indium-Ill antimy-
osin antibody scan be used to detect and monitor the natural 
course of viral myocarditis? 
To answer these questions, biodistribution studies were 
performed to verify results from antimyosin scanning, which 
were in turn confirmed by pathologic examination. 
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Methods 
Virus and cells. Encephalomyocarditis virus stock was 
prepared in cultures of VERO (African green monkey kid-
ney) cells in Eagle's minimum essential medium, and the 
suspensions were centrifuged after the development of a 
cytopathic effect. The titer of the virus stock, measured by 
the formation of plaque on VERO cell mono layers , was> 109 
plaque-forming units/O.I m!. Virus fluid was stored at -70°C 
until use. Cells were suspended at a concentration of I x 106 
in Eagle's minimum essential medium with 3% fetal calf 
serum and 100 p,g/ml of penicillin and streptomycin in six 
well plastic plates and were allowed to grow for 2 days at 
37°C in 5% carbon dioxide (C02), In plaque assays, volumes 
(0.1 m!) of decimal dilutions of virus suspended in Eagle's 
minimal essential medium were adsorbed onto VERO cell 
monolayers for 60 min at 37°C in 5% CO2, After adsorption, 
the cells were overlaid with 3 ml of medium containing 3% 
fetal calf serum and I % methyl cellulose. After 2 days of 
incubation (at 37°C) in a humidified atmosphere (5% CO2), 
the cells were fixed with acetic acid and methanol (at a ratio 
of 1:3) and stained with crystal violet (1%). Plaques were 
counted in an inverted microscope. 
Study protocol. These studies were carried out in con-
formance with the Position of the American Heart Associa-
tion on Research Animal Use. A total of 239 mice form the 
basis of this study; the 30 day segment included 84 mice. Six 
mice were killed on day 0 (before infection); after infection. 
six were killed on day 10, five on day 20 and five on day 30. 
An additional five mice served as an age-matched uninfected 
control group for the 30 day segment and were never 
inoculated. Because of the high incidence of death from the 
disease, it was necessary to inoculate 150 mice (in batches of 
about 20) to obtain 6 that survived to the 150 day end point. 
To exclude the possibility of prior infections, 9 to 11 week 
old inbred male C3H/He mice (Jackson Laboratories) were 
isolated for 2 weeks before injection of virus and observed 
daily. At the age of II to 13 weeks, the mice were inoculated 
intraperitoneally with 103 plaque-forming units/O.l ml of 
encephalomyocarditis virus. Twenty-eight mice were sub-
jected to radionuclide ventriculography, antimyosin scan 
and biodistribution study at day 0 (before infection, n = 6) 
and at days 10 (n = 6). 20 (n = 5),30 (n = 5) and 150 (n = 6) 
after infection. To monitor the serial ejection fraction values 
in naturally aging mice, the five uninfected control mice were 
subjected to ventriculography on days 0, 10 and 30. Imme-
diately after the radionuclide ventriculographic studies had 
been completed, indium-III antimyosin antibody imaging 
was performed at 24 and 48 h after injection; the preliminary 
data revealed that optimal targetlbackground ratios were 
obtained at 48 h. The mice were then killed by bleeding from 
the retroorbital plexus at the stated time points and 
necropsied. At necropsy, the heart and other organs were 
processed for indium-III antimyosin antibody biodistribu-
tion study, followed by histologic examination. Other mice 
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that had died as a result of infection were also processed for 
virologic study. 
Radionuclide ventriculography. After inoculation, radio-
nuclide ventriculograms could be performed without anes-
thesia because mice were less active (in part due to paralysis 
of the limbs). Before inoculation and on day 150, the mice 
required anesthesia by intraperitoneal injection of sodium 
pentobarbital (8). The dose necessary to reach an anesthetic 
threshold was 0.045 and 0.060 mg/g of body weight (by the 
method of Pilgrim and De Orne [9]), a dose that does not 
affect cardiac physiology. The animals were placed in a 
supine position. Stannous pyrophosphate (0.1 to 0.15 mg/ 
0.1 m!) was injected intravenously. Ten minutes later, 9 to 
14 mCi/0.05 ml of technetium-99m pertechnetate was in-
jected intravenously. The radio nuclide ventriculogram was 
acquired by electrocardiographic (ECG) gating with a 2 mm 
pinhole collimator. Images were recorded in a 32 x 32 matrix 
in the anterior projection. The gamma camera (Elscint) was 
peaked to 140 keV with a 20% window. For each image, data 
were collected over 5 min (10). Because it is impossible in 
many mice to distinguish between the right and left ventri-
cles (especially when the heart is dilated) on the radionuclide 
ventriculogram, we calculated a combined ejection fraction 
for both ventricles. 
Because of the small aperture pinhole collimator and the 
need to shorten the imaging time, we administered a rather 
large dose of technetium-99m pertechnetate. This was nec-
essary to prevent mice from dying from prolonged exposure 
to anesthesia and produce clear images. 
Indium-Ill antimyosin antibody cardiac scan. Mono-
clonal antibody 2G4 (a whole immunoglobulin G directed 
against the heavy chain of murine cardiac myosin) coupled 
to diethylene triamine pentaacetic acid for radiolabeling was 
used in this study. After the radiolabeled (130 p,Ci of 
indium-Ill in 0.1 to 0.2 m!) pyrogen-free 2G4 (100 p,g) had 
been administered intravenously. anterior static planar im-
ages (acquisition time of 10 min each) were obtained in a 256 
x 256 matrix at 24 and 48 h (Elscint Apex Camera. 2 mm 
pinhole collimator). Both energy peaks (that is, 173 and 
247 keV) were used with 10% windows. 
Planar images were interpreted directly from the com-
puter screen by at least three observers who had no knowl-
edge of the pathologic findings. Antimyosin uptake was 
graded as follows: 0 = normal. 1+ = possible uptake. 2 + = 
definite but not intense uptake « the sternal uptake), 3+ = 
definite, clear and intense uptake (= the sternal uptake), and 
4+ = very intense uptake (::::: hepatic uptake). For a more 
objective evaluation, the heart/lung count density ratio was 
also calculated. After a region of interest was delineated in 
the anterior image over the heart and lower right lung, the 
mean count density (counts/pixel) in each area was deter-
mined and the heart/lung ratio calculated. 
Biodistribution studies. These studies were performed to 
confirm antimyosin antibody 2G4 uptake by the heart and 
other organs by tissue counting and to characterize the 
distribution of the antibody. After the mice were killed. 
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indium-Ill antimyosin distribution was measured in the 
blood, heart, lungs, liver, sternum, ribs, pancreas, spleen, 
kidneys, psoas muscle, skull and brain, and data were 
expressed as the percent of injected dose per gram of tissue 
(11). The biodistribution studies are an essential verification 
of the imaging studies. 
Histopathology. Organs were fixed in 10% formalin solu-
tion and embedded in paraffin. Sections were made through 
the four chambers of the heart, stained with hematoxylin-
eosin and examined in serial sections. Myocardial lesions, 
cellular infiltration, myocardial cell necrosis and fibrosis 
were scored in terms of severity by two blinded observers as 
follows: 0 = no lesions, 1 + = one or two small foci, 2+ = 
several small foci, 3+ = mUltiple small or several large foci 
and 4+ = multiple large foci. 
Virus titers. For infectivity assays, the heart was re-
moved, weighed and homogenized aseptically in 2 ml of 
Eagle's minimum essential medium. After centrifugation at 
1,500 g for 15 min at 4°C, supernatant (0.1 mn was inoculated 
into VERO cell monolayers and plaque assays were per-
formed. 
Statistics. Data were subjected to one- and two-way 
analysis of variance (with multiple sample comparisons) 
according to the Newman-Keul method (12). Correlations 
were calculated by simple regression analysis. Results were 
expressed as mean ± standard deviation. 
Results 
Mortality and incidence of myocarditis. Of the 84 mice in 
the 30 day segment of the study, a total of 17 were killed for 
data sampling before day 30. Of the remaining 67 mice, 25 
infected mice (37%) died by day 10, 15 (22%) between days 
11 and 20 and 22 (33%) between days 21 and 30; 5 mice 
survived for 30 days. The total cumulative mortality rate by 
day 30 was 92.5%. The incidence of myocarditis was 100%, 
both in the mice that were killed (confirmed by microscopic 
examination) and in those that died of infection (confirmed 
by macroscopic examination). 
Radionuclide ventriculography (Table 1, Fig. 1). The 
baseline ejection fraction in the uninfected mice (day 0) was 
63.3 ± 3.1 %. Infected mice showed a lower ejection fraction 
on days 10 (20.7 ± 5.5%), 20 (18.6 ± 15.2%), 30 (18.5 ± 
7.7%) and 150 (30.0 ± 18.7%) in comparison with that in 
control mice (p < 0.001 in each group). Ejection fraction for 
the five age-matched control mice that had not been infected 
was constant and within normal range throughout the course 
of the study. The difference in ejection fraction between the 
infected group and the uninfected age-matched group was 
significant on days 10 and 30 (p < 0.001). 
Antimyosin scan (Table 1, Fig. 2). None of the un infected 
mice on day 0 (baseline) showed myocardial uptake (score of 
0). On day 10, dense antimyosin uptake was seen in the 
myocardium of all six mice (score of 2.5 ± 0.6). On day 20, 
however, small and focal uptake was seen in only one of five 
mice (score of 1). On days 30 and 150, only two mice had a 
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positive score (score of 2 and 1, and 1.5 and 0.5, respective-
ly). The heart/lung ratio of the mean count density in the 
region of interest drawn around the heart and lungs is also 
shown in Table 1. There was a good correlation (p < 0.000 1) 
between the scores by subjective grading of antimyosin scan 
and the calculations of heart/lung ratio. 
Biodistribution of indium-111 antimyosin antibody and 
myocardium to blood ratios (Table 2). Uptake in the myo-
cardium was measured in the whole heart. The heart to 
blood uptake ratio on day 10 was high (p < 0.001 versus that 
in the mice before infection), but not on days 20, 30 and 150. 
As already described (Table 1), myocardial uptake grade and 
heart/lung count density ratio correlated well. 
Pathologic findings (Table 1, Fig. 3). Serial pathologic 
studies in this model have been described elsewhere (7,8). In 
brief, by days 3 to 4, the mice appeared irritable and ill (with 
coat ruffling). Paralysis of the lower limbs first appeared on 
day 5, when yellow-white patches could be seen macroscop-
ically on the surface of the heart. On day 10, paralysis ofthe 
lower limbs was fixed. At this stage, marked cellular infil-
tration and myocardial necrosis were evident microscopi-
cally (Fig. 3). On day 20, cellular infiltration and myocardial 
necrosis decreased, and the process of healing (that is, 
evidence of fibrosis) commenced. Pleural effusion and as-
cites were found on days 10 through 30, and pulmonary and 
hepatic congestion was evident microscopically. With the 
exception of the brain and pancreas, neither inflammatory 
nor necrotic lesions were noted in other organs. No abnor-
malities were found in organs from the uninfected mice. 
Virologic study. Encephalomyocarditis virus was iso-
lated from the hearts of mice on days 8 and 9 (14.17 ± 5.17 
x 106 plaque-forming units/g tissue, n = 9) and on days 10 
and 11 (7.19 ± 7.75 x 104 plaque-forming units/g tissue, n = 
10). No virus was isolated on days 15 through 21 (n = 5). 
Discussion 
Murine viral myocarditis. The evolution of cardiac histo-
pathology in this model of viral myocarditis is in agreement 
with our previous studies (7,8). Infiltration and necrosis were 
most severe at 10 days after infection; infiltration was absent 
at 150 days (except in one of six mice), although focal 
necrosis was still visible; fibrosis appeared as early as day 10 
and progressed until day 20, but stabilized thereafter. 
Although murine myocarditis induced by infection with a 
cardiotropic strain of the encephalomyocarditis virus has 
been studied extensively (7,8), ours is the first study of 
global cardiac systolic function in the mouse model. Against 
a background of reasonably reproducible and constant val-
ues in control mice, the present study indicates a significant, 
substantial and consistent decrease in systolic function at 10, 
20 and 30 days after infection and a partial recovery 150 days 
after infection. This pattern of change in systolic function 
correlates well with the degree of cellular infiltration and 
myocardial necrosis. 
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Table 1. Radionuclide Ejection Fraction, Antimyosin Scan Grade (uptake in heart), Heart/Lung 
Mean Count Density Ratio for Antimyosin Scan and Histopathologic Grade of Myocarditis 
Days 
Mouse No. o (n = 6) 10 (n = 6) 20 (n = 5) 30 (n = 5) 150 (n = 6) 
EF(%)* 
1 60 25 6 12 7 
2 64 22 14 23 9 
3 62 14 12 27 40 
4 69 15 45 -t 45 
5 62 20 16 12 28 
6 63 28 51 
6303 ± 3.1 20.7 ± 5.5~ 18.6 ± 15.2~ 18.5 ± 7.7t 30.0 ± 18.7t 
Antimyosin scan 
(uptake 0 to 4+) 
1 0 3.5 -§ 2.011 0 
2 0 3.0 0 1.0 1.5 
3 0 2.5 1.0 0 0 
4 0 2.0 0 -t 0 
5 0 2.0 0 0 0.5 
6 0 2.0 0 
o ± 0 2.5 ± 0.6~ OJ ± 0.5 0.8 ± 1.0 OJ ± 0.6 
Antimyosin scan heart/lung ratio 
(mean count density ratio) 
1 1.42 5.22 -§ 2.1511 0.83 
2 1.07 3.67 0.86 1.14 1.57 
3 1.15 2.75 1.09 1.38 1.15 
4 0.80 2.94 0.89 -t 0.92 
5 1.09 2035 1.00 1.04 1045 
6 1.28 1.92 0.93 
1.14 ± 0.21 3.14 ± 1.l7t 0.96 ± 0.11 1.43 ± 0.50 1.14 ± OJ 1 
Infiltration 
1 0 3 2 0 
2 0 3 3 
3 0 2 0 
4 0 2 0 
5 0 4 2 0 
6 0 4 0 
o ± 0 303 ± 0.5~ 2.2 ± 0.8t 1.4 ± O.5t 0.2 ± 004 
Pathologic grade 
(0 to 4+) 
Necrosis 
1 0 4 3 
2 0 4 3 2 2 
3 0 4 3 2 
4 0 4 3 2 1 
5 0 4 4 4 2 
6 0 4 2 
o ± 0 4.0 ± O.O~ 3.2 ± OA~ 2.6 ± 0.9~ 1.5 ± 0.5~ 
Fibrosis 
1 0 2 2 
2 0 2 3 2 
3 0 2 2 2 
4 0 1 2 2 2 
5 0 2 2 3 3 
6 0 
O±O 103 ± 0.5:j: 2.2 ± OAt 204 ± 0.5:j: 2.0 ± 0.6t 
*Ejection fraction (EF) was evaluated in a group of five uninfected mice (data not shown) on days 0, 10 and 30 
and was found to be almost constant: day 0 = 59.2 ± 5.7%; day \0 = 53.2 ± 2.2%; day 30 = 56.8 ± 11.2%. tThis 
mouse died ofrhythm disturbance during radionuclide ventriculography. :j:p < 0.001 versus values on day O. §This 
mouse died 24 h after radionuclide ventriculography but before antimyosin scan. IIThis mouse died 24 h after 
antimyosin scan. Values are mean ± SD. 
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Figure 1. Radionuclide ventriculograms and time-activity curves in 
diseased (A and B) and uninfected (C and D) mice. Ejection fraction 
(E.F.) in an infected mouse on day 10 (6%, A and B) was apparently 
low compared with that in a control mouse (60%, C and D). Also 
note that the separation of the left and right ventricles was not clear 
in the enlarged diseased heart. However, in the control mouse, the 
right and left ventricles are separated by the septum. ED = 
end-diastole; ES = end-systole. 
Antimyosin antibody scans to diagnose acute myocarditis. 
Radiolabeled immunoglobulin G antibodies to myosin bind 
cells that have lost the integrity of their plasma membranes: 
when the membrane degenerates, intracellular myosin is 
exposed to extracellular fluid. Scintigraphic examinations 
with these antibodies have been used to localize and quantify 
regions of myocardial necrosis in myocardial infarction 
(13-17). In a clinical study of antimyosin antibody scans in a 
series of 28 patients suspected of having myocarditis, Ya-
suda et al. (5) reported a sensitivity of 100% but a specificity 
of only 58%. Most recently, Matsumori et al. (18) studied the 
myocardial uptake of iodine-125- and iodine-131-labeled 
monoclonal antimyosin Fab in experimental murine viral 
encephalomyocarditis over a period of 28 days. They (18) 
showed that antimyosin Fab localized selectively in hearts 
Figure 2. Antimyosin antibody scan. Note the dense myocardial 
uptake (arrow) in a diseased mouse on day 10 (A) and the normal 
uptake in a control mouse (B). 
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from the acute and subacute stages of the disease. Because 
myocardial necrosis is an essential manifestation of the 
disease process, the present study confirms the applicability 
of radiolabeled antimyosin imaging in the diagnosis of myo-
carditis . Indeed, the results of the biodistribution studies 
confirm that there is an abnormal accumulation of indium-
III antimyosin antibody in diseased hearts. The data also 
demonstrate that a negative anti myosin scan reflects either 
the absence of or the healing stage of myocarditis. Therefore 
in the clinical setting, a negative antimyosin scan probably 
excludes the presence of myocarditis in the acute phase. 
Correlation with histopathologic findings. Myocardial up-
take of antimyosin antibody, as revealed by in vivo scan-
ning, was strongly positive at 10 days after infection, a time 
at which histopathologic evidence of necrosis was also 
maximal. Thereafter, uptake was sporadic and weak. In 
agreement with these results, in vitro uptake of indium-III 
in heart tissue was significant only on day 10. Our hypothesis 
is that in the early stage of myocardial necrosis, there is an 
abundant supply of myosin binding sites still in possession of 
a molecular structure recognizable by antimyosin antibod-
ies . With the passage of time the structure probably loses its 
specificity for the antibodies and binding to necrotic areas 
decreases . This would explain the discrepancy after day 10 
between the degree of necrosis by pathologic criteria and 
that by antimyosin antibody uptake. In any case, the results 
of this study fulfill expectations about antimyosin antibody 
uptake: uptake correlates well with evidence of acute myo-
cardial necrosis by histopathology and with evidence of 
systolic dysfunction. 
Systolic function in myocarditis. Previous studies (7,8,19) 
of viral encephalomyocarditis provide evidence of depressed 
cardiac function by several indirect criteria (namely, cardiac 
pathology, congestion of the lungs and liver and low voltage 
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Figure 3. Cardiac histopathologic 
specimen from an infected mouse on 
day 10 (same mouse as in Fig. 2A). 
Prominent cellular infiltration with ac-
tive myocardial necrosis is evident. 
Hematoxylin-eosin stain x500, re-
duced by 31%. 
QRS complexes with tachycardia on the ECG). In the 
present study, we measured ejection fraction directly by 
ECG-gated ventriculograph y. The marked decrease in ejec-
tion fraction in the acute and subacute stages of myocarditis 
and the partial recovery of ejection fraction in the chronic 
stage parallel what has been observed in clinical settings. 
The depression of global cardiac function in the acute stage 
is associated with severe myocardial damage and intense 
myocardial uptake of antimyosin. Mice that survived the 
acute stage tended to show less myocardial necrosis and less 
uptake of antimyosin in the myocardium; indeed, the ejec-
tion fraction in mice on day 150 was higher than that on day 
10. This could reflect the survival or recovery of mice least 
affected by the disease. 
It is of interest that even in the chronic stage , some mice 
(two of five on day 30 and two of six on day 150) showed 
positive antimyosin uptake associated with a low ejection 
fraction, which suggests active and ongoing myocardial 
necrosis. Even after careful evaluation of cardiac pathology 
(light microscopy of hematoxylin-eosin stained samples), no 
definitive evidence of the active process of myocardial 
necrosis could be found. It must be recognized, however, 
that notwithstanding the genetic homogeneity and uniform 
sensitivity of the mice to the virus, the survivors were 
heterogeneous in cardiac function and pathology. 
Clinical implications. Although this experimental study 
involves a single virus (not pathogenic to humans), one 
inbred strain of mice and a known time of infection as 
opposed to clinical studies that involve mUltiple viruses (or 
other causes of myocardial damage), an outbred species and 
unknown duration of disease, a valid comparison can be 
made between the time course of myocarditis in these two 
settings. The period of 10 days after infection in the murine 
model would be comparable with the onset of clinical 
lACC Vol. 17, No.3 
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symptoms (the appearance of chest pain, ECG abnormalities 
and other cardiac manifestations of disease) (19,20). The 20 
day period would mirror the stage of definitive clinical 
manifestations of myocarditis and severe cardiac dysfunc-
tion. Thus, antimyosin antibody imaging may be the first 
noninvasive method for the detection of necrotic processes 
underlying even the chronic stage of myocarditis, during 
which unknown or immune mechanisms may be in operation 
(8,20,21). In the setting of increasing evidence of the lack of 
sensitivity of endomyocardial biopsy for the detection of 
active myocarditis in humans the results of this experimental 
study support the conclusions of our pilot clinical study (5) 
and justify further evaluation of antimyosin scanning in the 
diagnosis of myocarditis. 
We thank Kathryn A. Thorp for technical help. Joan Burke and Tom 
McVarish for assistance in preparing the manuscript and Rosemary Kennedy 
for support in carrying out this project. 
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